tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

SKYE Stock Latest News

Strategic Collaboration and Promising Therapeutic Approaches Drive Buy Rating for Skye Bioscience
RatingsStrategic Collaboration and Promising Therapeutic Approaches Drive Buy Rating for Skye Bioscience
19d ago
SKYE
Skye Bioscience’s Promising Peripheral CB1R Obesity Treatment Drives Buy Rating
PremiumRatings
Skye Bioscience’s Promising Peripheral CB1R Obesity Treatment Drives Buy Rating
26d ago
SKYE
Skye Bioscience presents PK, PD model on CB1 inhibitors
PremiumThe Fly
Skye Bioscience presents PK, PD model on CB1 inhibitors
26d ago
SKYE
Skye Bioscience price target lowered to $17 from $21 at Oppenheimer
PremiumThe Fly
Skye Bioscience price target lowered to $17 from $21 at Oppenheimer
27d ago
SKYE
Promising Developments and Strong Clinical Engagement Lead to Buy Rating for Skye Bioscience
PremiumRatings
Promising Developments and Strong Clinical Engagement Lead to Buy Rating for Skye Bioscience
30d ago
SKYE
Skye Bioscience Q1 2025: Progress in Obesity Treatment
PremiumCompany AnnouncementsSkye Bioscience Q1 2025: Progress in Obesity Treatment
1M ago
SKYE
Skye Bioscience reports Q1 EPS (28c), consensus (29c)
Premium
The Fly
Skye Bioscience reports Q1 EPS (28c), consensus (29c)
1M ago
SKYE
Skye Bioscience announces inducement grant under Nasdaq listing rule
Premium
The Fly
Skye Bioscience announces inducement grant under Nasdaq listing rule
1M ago
SKYE
Skye Bioscience announces new preclinical data for nimacimab
PremiumThe Fly
Skye Bioscience announces new preclinical data for nimacimab
2M ago
SKYE
Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress
PremiumCompany Announcements
Skye Bioscience’s Positive Earnings Call Highlights Nimacimab Progress
3M ago
SKYE
Skye Bioscience: Strategic Advancements and Robust Financial Health Support Buy Rating
PremiumRatings
Skye Bioscience: Strategic Advancements and Robust Financial Health Support Buy Rating
3M ago
SKYE
Skye Bioscience price target lowered to $14 from $18 at Craig-Hallum
PremiumThe Fly
Skye Bioscience price target lowered to $14 from $18 at Craig-Hallum
3M ago
SKYE
Skye Bioscience Reports 2024 Financial Results and Trial Progress
PremiumCompany AnnouncementsSkye Bioscience Reports 2024 Financial Results and Trial Progress
3M ago
SKYE
Skye Bioscience reports Q4 EPS (24c), consensus (24c)
Premium
The Fly
Skye Bioscience reports Q4 EPS (24c), consensus (24c)
3M ago
SKYE
Is SKYE a Buy, Before Earnings?
Premium
Pre-Earnings
Is SKYE a Buy, Before Earnings?
3M ago
SKYE
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
IPA
PBM
Skye Bioscience initiated with an Outperform at William Blair
PremiumThe Fly
Skye Bioscience initiated with an Outperform at William Blair
3M ago
SKYE
Skye Bioscience’s Innovative Approach in Obesity Market Garners Buy Rating Amid Promising Market Potential
PremiumRatings
Skye Bioscience’s Innovative Approach in Obesity Market Garners Buy Rating Amid Promising Market Potential
3M ago
SKYE
Skye Bioscience Updates Inducement Equity Incentive Plan
PremiumCompany Announcements
Skye Bioscience Updates Inducement Equity Incentive Plan
3M ago
8K
SKYE
Skye Bioscience provides 2025 look ahead, anticipated milestones
PremiumThe FlySkye Bioscience provides 2025 look ahead, anticipated milestones
5M ago
SKYE
Skye Bioscience achieved more than 50% targeted patient enrollment in CBeyond
Premium
The Fly
Skye Bioscience achieved more than 50% targeted patient enrollment in CBeyond
7M ago
SKYE
Skye Bioscience Reports Progress in Obesity Drug Trials
Premium
Company Announcements
Skye Bioscience Reports Progress in Obesity Drug Trials
7M ago
SKYE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >